Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol

Elesclomol is a first-in-class investigational drug currently undergoing clinical evaluation as a novel cancer therapeutic. The potent antitumor activity of the compound results from the elevation of reactive oxygen species (ROS) and oxidative stress to levels incompatible with cellular survival. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, Ronald K., Cheung-Ong, Kahlin, Gebbia, Marinella, Proia, David A., He, Suqin, Kepros, Jane, Jonneaux, Aurelie, Marchetti, Philippe, Kluza, Jerome, Rao, Patricia E., Wada, Yumiko, Giaever, Guri, Nislow, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256171/
https://www.ncbi.nlm.nih.gov/pubmed/22253786
http://dx.doi.org/10.1371/journal.pone.0029798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256171/
https://www.ncbi.nlm.nih.gov/pubmed/22253786
http://dx.doi.org/10.1371/journal.pone.0029798

Ejemplares similares